NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sable Offshore Corp. ("Sable" or "the Company") (NYSE:SOC). Investors who purchased Sable securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/SOC. […]

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX). Investors who purchased TransMedics securities prior to February 3, 2022, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dyne Therapeutics, Inc. ("Dyne" or "the Company") (NASDAQ:DYN). Investors who purchased Dyne securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/DYN.

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sun Communities, Inc. ("Sun Communities" or "the Company") (NYSE:SUI). Investors who purchased Sun Communities securities prior to February 28, 2019, and continue to hold to the present, are encouraged

NEW YORK, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DMC Global Inc. ("DMC Global" or "the Company") (NASDAQ:BOOM). Investors who purchased DMC Global securities prior to January 29, 2024, and continue to hold to the present, are encouraged to

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teradata Corporation ("Teradata" or "the Company") (NYSE:TDC). Investors who purchased Teradata securities prior to February 13, 2023, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sprout Social, Inc. ("Sprout" or "the Company") (NASDAQ:SPT). Investors who purchased Sprout securities prior to November 3, 2021, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sage Therapeutics, Inc. ("Sage" or "the Company") (NASDAQ:SAGE). Investors who purchased Sage securities prior to April 12, 2021, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Equinix, Inc. ("Equinix" or "the Company") (NASDAQ:EQIX). Investors who purchased Equinix securities prior to May 3, 2019, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Extreme Networks, Inc. ("Extreme Networks" or "the Company") (NASDAQ:EXTR). Investors who purchased Extreme Networks securities prior to July 27, 2022, and continue to hold to the present, are encouraged